Celsion Extends Losses
Posted on February 04, 2013 at 12:29 PM EST
Shares of Celsion Corp. (Nasdaq: CLSN) continued falling by slipping 15 cents to $1.17 after reporting disappointing study results last week for its ThermoDox in treating liver cancer patients.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here